<DOC>
	<DOCNO>NCT02605070</DOCNO>
	<brief_summary>Single center , prospective , open clinical study determine genomic imprint ( epigenetic modification ) series male infertility patient alteration spermiogram ( oligozoospermia ) compare group fertile patient order evaluate effect FSH ( follicle stimulate hormone ) administration modification male infertility .</brief_summary>
	<brief_title>Pilot Study Effects FSH Treatment Epigenetic Characteristics Spermatozoa Infertile Patients With Severe Oligozoospermia</brief_title>
	<detailed_description>Single center , prospective , open clinical study determine genomic imprint ( epigenetic modification ) series male infertility patient alteration spermiogram ( oligozoospermia ) compare group fertile patient order evaluate effect FSH ( follicle stimulate hormone ) administration modification male infertility . Main objective : To determine genomic imprint ( epigenetic modification ) series male infertility patient alteration spermiogram ( oligozoospermia ) compare group fertile patient order evaluate effect FSH administration modification male infertility . Secondary objective - To assess main characteristic spermiograms infertility patient FSH treatment . - To assess modification hormone involve sperm formation infertility patient treatment . - To analyze result assisted reproduction treatment patient receive FSH treatment .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility , Male</mesh_term>
	<mesh_term>Oligospermia</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>Inclusion criterion infertility treatment group ( n=30 ) 1 . Between 3045 year age . 2 . Total sperm concentration ( concentration millions/mL x volume mL ) 110 million ( oligozoospermia ) least 2 spermiograms obtain 24 day period sexual abstinence 7day separation period test . 3 . Caucasian . 4 . Inability couple become pregnant one year sexual relation without use type contraception . 5 . FSH 212 IU/mL . 6 . Total testosterone &gt; 300 ng/mL bioavailable testosterone ( calculate Sexual Hormone Binding Globulin SHBG albumin ) &gt; 145 ng/dL . Inclusion criterion control group fertile male ( n=15 ) 1 . Between 3045 year age . 2 . Caucasian . 3 . Sperm concentration motility 5th percentile accord parameter set forth 5th edition World Health Organization ( WHO ) guideline least two spermiograms obtain 24 day period sexual abstinence 7day period test . 4 . Seminal volume &gt; 1 mL . 5 . Estradiol &lt; 50 pg/mL 6 . FSH &lt; 4.5 IU/L . 7 . Total testosterone &gt; 300 ng/dL bioavailable testosterone &gt; 145 ng/dL . 8 . No vasectomy . 9 . Has sire child within past 5 year . Exclusion criterion infertility treatment group . 1 . Total sperm concentration &lt; 1 million . 2 . Sperm motility 0 % . 3 . History varicocele , cryptorchidism , malignant benign tumor , know chromosomal abnormality , testicular tor sion , testicular trauma , orchitis . 4 . Smoking past 120 day . thyroid dysfunction 5 . Drug use past 120 day . thyroid dysfunction 6 . Medical history : thyroid dysfunction , blood disease , diabetes . 7 . Use anabolic steroid past 2 year 2 year . 8 . Body mass index &gt; 30 kg/m . 9 . Intake 21 unit alcohol/week past 120 day .</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>